The impact of mitochondrial aldehyde dehydrogenase (ALDH2) activation by Alda-1 on the behavioral and biochemical disturbances in animal model of depression

Brain, Behavior, and Immunity

Volumn 51, Issue , 2016, Pages 144-153

  Stachowicz, Aneta ^a   Głombik, Katarzyna ^b   Olszanecki, Rafał ^a   Basta Kaim, Agnieszka ^b   Suski, Maciej ^a   Lasoń, Władysław ^b   Korbut, Ryszard ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Alda 1; ALDH2; Behavior; Depression; Immunoreactivity; Mitochondria

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ANTIDEPRESSANT AGENT; MESSENGER RNA; N (1,3 BENZODIOXOL 5 YLMETHYL) 2,6 DICHLOROBENZAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; ALDH2 PROTEIN, RAT; BENZAMIDE DERIVATIVE; CYTOKINE; N-(1,3-BENZODIOXOL-5-YLMETHYL)-2,6-DICHLOROBENZAMIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ANXIETY DISORDER; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; CELL FUNCTION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ELEVATED PLUS MAZE TEST; ENZYME ACTIVATION; FEMALE; FORCED SWIM TEST; FRONTAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; IMMOBILITY; IMMUNOREACTIVITY; MALE; MITOCHONDRIAL BIOGENESIS; NONHUMAN; PRENATAL STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; SPRAGUE DAWLEY RAT; ANIMAL; ANXIETY; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; FRONTAL LOBE; LYMPHOCYTE; MENTAL STRESS; METABOLISM; MITOCHONDRION; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGY;

ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL; ANIMALS; ANXIETY; APOPTOSIS; BENZAMIDES; BENZODIOXOLES; CELL PROLIFERATION; CYTOKINES; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; LYMPHOCYTES; MALE; MITOCHONDRIA; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84939477733     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.08.004     Document Type: Article

References (56)

1. Alcocer-Gómez, E., de Miguel, M., Casas-Barquero, N., Núñez-Vasco, J., Sánchez-Alcazar, J.A., Fernández-Rodríguez, A., Cordero, M.D., NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain. Behav. Immun. 36 (2014), 111–117.
2. Bonnefont, J.-P., Djouadi, F., Prip-Buus, C., Gobin, S., Munnich, A., Bastin, J., Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol. Aspects Med. 25 (2004), 495–520.
3. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254.
4. Budziszewska, B., Szymanska, M., Leskiewicz, M., Basta-Kaim, A., Jaworska-Feil, L., Kubera, M., Jantas, D., Lason, W., The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. J. Physiol. Pharmacol. 61 (2010), 207–215.
5. Chan, J.Y.H., Cheng, H.-L., Chou, J.L.J., Li, F.C.H., Dai, K.-Y., Chan, S.H.H., Chang, A.Y.W., Heat shock protein 60 or 70 activates nitric-oxide synthase (NOS) I- and inhibits NOS II-associated signaling and depresses the mitochondrial apoptotic cascade during brain stem death. J. Biol. Chem. 282 (2007), 4585–4600.
6. Chen, C.-H., Budas, G.R., Churchill, E.N., Disatnik, M.-H., Hurley, T.D., Mochly-Rosen, D., Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321 (2008), 1493–1495.
7. Chen, F., Wegener, G., Madsen, T.M., Nyengaard, J.R., Mitochondrial plasticity of the hippocampus in a genetic rat model of depression after antidepressant treatment. Synapse (New York, NY) 67 (2013), 127–134.
8. Chiou, S.-H., Chen, S.-J., Peng, C.-H., Chang, Y.-L., Ku, H.-H., Hsu, W.-M., Ho, L.L.-T., Lee, C.-H., Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. Biochem. Biophys. Res. Commun. 343 (2006), 391–400.
9. Chiu, C.-C., Yeh, T.-H., Lai, S.-C., Wu-Chou, Y.-H., Chen, C.-H., Mochly-Rosen, D., Huang, Y.-C., Chen, Y.-J., Chen, C.-L., Chang, Y.-M., et al. Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism. Exp. Neurol. 263 (2015), 244–253.
10. Chu, C.-C., Wang, J.-J., Chen, K.-T., Shieh, J.-P., Wang, L.-K., Shui, H.-A., Ho, S.-T., Neurotrophic effects of tianeptine on hippocampal neurons: a proteomic approach. J. Proteome Res. 9 (2010), 936–944.
11. Detke, M.J., Rickels, M., Lucki, I., Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl.) 121 (1995), 66–72.
12. Drevets, W.C., Price, J.L., Furey, M.L., Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 213 (2008), 93–118.
13. Du, Z., Gao, J., Wang, W., Yu, C., Dou, X., Synergistic action of 4-hydroxynonenal and tumor necrosis factor involving the NF-kB/IkBa signaling pathway in alcohol-induced liver injury. Zhonghua Gan Zang Bing Za Zhi 21 (2013), 747–752.
14. Endo, J., Sano, M., Katayama, T., Hishiki, T., Shinmura, K., Morizane, S., Matsuhashi, T., Katsumata, Y., Zhang, Y., Ito, H., et al. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. Circ. Res. 105 (2009), 1118–1127.
15. Ertenli, I., Ozer, S., Kiraz, S., Apras, S.B., Akdogan, A., Karadag, O., Calguneri, M., Kalyoncu, U., Infliximab, a TNF-α antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol. Int. 32 (2012), 323–330.
16. Feng, Z., Zou, X., Jia, H., Li, X., Zhu, Z., Liu, X., Bucheli, P., Ballevre, O., Hou, Y., Zhang, W., et al. Maternal docosahexaenoic acid feeding protects against impairment of learning and memory and oxidative stress in prenatally stressed rats: possible role of neuronal mitochondria metabolism. Antioxid. Redox Signal. 16 (2012), 275–289.
17. Gardner, A., Boles, R.G., Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 35 (2011), 730–743.
18. Gardner, A., Johansson, A., Wibom, R., Nennesmo, I., von Döbeln, U., Hagenfeldt, L., Hällström, T., Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J. Affect. Disord. 76 (2003), 55–68.
19. Głombik, K., Stachowicz, A., Ślusarczyk, J., Trojan, E., Budziszewska, B., Suski, M., Kubera, M., Lasoń, W., Wędzony, K., Olszanecki, R., et al. Maternal stress predicts altered biogenesis and the profile of mitochondrial proteins in the frontal cortex and hippocampus of adult offspring rats. Psychoneuroendocrinology 60 (2015), 151–162.
20. Guan, L., Jia, N., Zhao, X., Zhang, X., Tang, G., Yang, L., Sun, H., Wang, D., Su, Q., Song, Q., et al. The involvement of ERK/CREB/Bcl-2 in depression-like behavior in prenatally stressed offspring rats. Brain Res. Bull. 99 (2013), 1–8.
21. Guo, Y., Yu, W., Sun, D., Wang, J., Li, C., Zhang, R., Babcock, S.A., Li, Y., Liu, M., Ma, M., et al. A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy. Biochim. Biophys. Acta., 2014.
22. He, J., Luo, H., Yan, B., Yu, Y., Wang, H., Wei, Z., Zhang, Y., Xu, H., Tempier, A., Li, X., et al. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 30 (2009), 1205–1216.
23. Hensley, K., Venkova, K., Christov, A., Gunning, W., Park, J., Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol. 43 (2011), 180–191.
24. Johnston-Wilson, N.L., Sims, C.D., Hofmann, J.P., Anderson, L., Shore, A.D., Torrey, E.F., Yolken, R.H., Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatry 5 (2000), 142–149.
25. Koll, H., Guiard, B., Rassow, J., Ostermann, J., Horwich, A.L., Neupert, W., Hartl, F.U., Antifolding activity of hsp60 couples protein import into the mitochondrial matrix with export to the intermembrane space. Cell 68 (1992), 1163–1175.
26. Liu, M.-E., Huang, C.-C., Yang, A.C., Tu, P.-C., Yeh, H.-L., Hong, C.-J., Chen, J.-F., Liou, Y.-J., Lin, C.-P., Tsai, S.-J., Effect of Bcl-2 rs956572 polymorphism on age-related gray matter volume changes. PloS One, 8, 2013, e56663.
27. MacAskill, A.F., Atkin, T.A., Kittler, J.T., Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. Eur. J. Neurosci. 32 (2010), 231–240.
28. Magnoni, R., Palmfeldt, J., Hansen, J., Christensen, J.H., Corydon, T.J., Bross, P., The Hsp60 folding machinery is crucial for manganese superoxide dismutase folding and function. Free Radical Res. 48 (2014), 168–179.
29. Mairesse, J., Silletti, V., Laloux, C., Zuena, A.R., Giovine, A., Consolazione, M., van Camp, G., Malagodi, M., Gaetani, S., Cianci, S., et al. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats. Int. J. Neuropsychopharmacol. 16 (2013), 323–338.
30. Marchitti, S.A., Deitrich, R.A., Vasiliou, V., Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol. Rev. 59 (2007), 125–150.
31. Mattson, M.P., Gleichmann, M., Cheng, A., Mitochondria in neuroplasticity and neurological disorders. Neuron 60 (2008), 748–766.
32. Meyer, U., Feldon, J., Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 90 (2010), 285–326.
33. Ohta, S., Ohsawa, I., Kamino, K., Ando, F., Shimokata, H., Mitochondrial ALDH2 deficiency as an oxidative stress. Ann. N. Y. Acad. Sci. 1011 (2004), 36–44.
34. Onyango, I.G., Lu, J., Rodova, M., Lezi, E., Crafter, A.B., Swerdlow, R.H., Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochim. Biophys. Acta 1802 (2010), 228–234.
35. Pan, Y., Chen, X.-Y., Zhang, Q.-Y., Kong, L.-D., Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats. Brain. Behav. Immun. 41 (2014), 90–100.
36. Perez-Miller, S., Younus, H., Vanam, R., Chen, C.-H., Mochly-Rosen, D., Hurley, T.D., Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat. Struct. Mol. Biol. 17 (2010), 159–164.
37. Porsolt, R.D., Anton, G., Blavet, N., Jalfre, M., Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978), 379–391.
38. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., Haroon, E., Miller, A.H., A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70 (2013), 31–41.
39. Rezin, G.T., Amboni, G., Zugno, A.I., Quevedo, J., Streck, E.L., Mitochondrial dysfunction and psychiatric disorders. Neurochem. Res. 34 (2009), 1021–1029.
40. Ronis, M.J.J., Mercer, K.E., Gannon, B., Engi, B., Zimniak, P., Shearn, C.T., Orlicky, D.J., Albano, E., Badger, T.M., Petersen, D.R., Increased 4-hydroxynonenal protein adducts in male GSTA4-4/PPARΑ double knockout mice enhance injury during early stages of alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol., 2014 ajpgi.00154.2014.
41. Rosenblat, J.D., Cha, D.S., Mansur, R.B., McIntyre, R.S., Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 53 (2014), 23–34.
42. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J.V., Mann, M., In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1 (2006), 2856–2860.
43. Stachowicz, A., Olszanecki, R., Suski, M., Wiśniewska, A., Totoń-Żurańska, J., Madej, J., Jawień, J., Białas, M., Okoń, K., Gajda, M., et al. Mitochondrial aldehyde dehydrogenase activation by alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein e-knockout mice. J. Am. Heart Assoc., 3, 2014.
44. Stefanis, L., Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry 11 (2005), 50–62.
45. Stertz, L., Magalhães, P.V.S., Kapczinski, F., Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr. Opin. Psychiatry 26 (2013), 19–26.
46. Streck, E.L., Gonçalves, C.L., Furlanetto, C.B., Scaini, G., Dal-Pizzol, F., Quevedo, J., Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders. Rev. Bras. Psiquiatr. 1999:36 (2014), 156–167.
47. Sutterwala, F.S., Haasken, S., Cassel, S.L., Mechanism of NLRP3 inflammasome activation. Ann. N. Y. Acad. Sci. 1319 (2014), 82–95.
48. Szczesny, E., Basta-Kaim, A., Slusarczyk, J., Trojan, E., Glombik, K., Regulska, M., Leskiewicz, M., Budziszewska, B., Kubera, M., Lason, W., The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: the possible role of suppressors of cytokine signaling proteins. J. Neuroimmunol. 276 (2014), 37–46.
49. Szymańska, M., Budziszewska, B., Jaworska-Feil, L., Basta-Kaim, A., Kubera, M., Leśkiewicz, M., Regulska, M., Lasoń, W., The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology 34 (2009), 822–832.
50. Taler, M., Bar, M., Korob, I., Lomnitski, L., Baharav, E., Grunbaum-Novak, N., Weizman, A., Gil-Ad, I., Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders. Int. Immunopharmacol. 8 (2008), 526–533.
51. Tamura, M., Sajo, M., Kakita, A., Matsuki, N., Koyama, R., Prenatal stress inhibits neuronal maturation through downregulation of mineralocorticoid receptors. J. Neurosci. 31 (2011), 11505–11514.
52. Tobe, E.H., Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatr. Dis. Treat. 9 (2013), 567–573.
53. Videbech, P., PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr. Scand. 101 (2000), 11–20.
54. Wang, J., Dunn, A.J., Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem. Int. 33 (1998), 143–154.
55. Wang, J.-F., Shao, L., Sun, X., Young, L.T., Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 11 (2009), 523–529.
56. Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R.C., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 (1999), 115–124.